[2]
Antin JH,Kim HT,Cutler C,Ho VT,Lee SJ,Miklos DB,Hochberg EP,Wu CJ,Alyea EP,Soiffer RJ, Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood. 2003 Sep 1
[PubMed PMID: 12730113]
[3]
Shimabukuro-Vornhagen A,Liebig T,von Bergwelt-Baildon M, Statins inhibit human APC function: implications for the treatment of GVHD. Blood. 2008 Aug 15
[PubMed PMID: 18684883]
[4]
Mielcarek M,Martin PJ,Leisenring W,Flowers ME,Maloney DG,Sandmaier BM,Maris MB,Storb R, Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 2003 Jul 15
[PubMed PMID: 12663454]
[5]
Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet (London, England). 2009 May 2:373(9674):1550-61. doi: 10.1016/S0140-6736(09)60237-3. Epub 2009 Mar 11
[PubMed PMID: 19282026]
[6]
Jamil MO,Mineishi S, State-of-the-art acute and chronic GVHD treatment. International journal of hematology. 2015 May
[PubMed PMID: 25864189]
[7]
Atkinson K,Horowitz MM,Gale RP,van Bekkum DW,Gluckman E,Good RA,Jacobsen N,Kolb HJ,Rimm AA,Ringdén O, Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 1990 Jun 15
[PubMed PMID: 2350582]
[8]
MacMillan ML,Robin M,Harris AC,DeFor TE,Martin PJ,Alousi A,Ho VT,Bolaños-Meade J,Ferrara JL,Jones R,Arora M,Blazar BR,Holtan SG,Jacobsohn D,Pasquini M,Socie G,Antin JH,Levine JE,Weisdorf DJ, A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Apr
[PubMed PMID: 25585275]
[9]
Gale RP,Bortin MM,van Bekkum DW,Biggs JC,Dicke KA,Gluckman E,Good RA,Hoffmann RG,Kay HE,Kersey JH, Risk factors for acute graft-versus-host disease. British journal of haematology. 1987 Dec
[PubMed PMID: 3322360]
[10]
Comments on survey., Baynai SE,, The Journal of the Michigan Dental Association, 1977 Feb
[PubMed PMID: 28373413]
Level 3 (low-level) evidence
[11]
Salomao M,Dorritie K,Mapara MY,Sepulveda A, Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver: An Update. American journal of clinical pathology. 2016 May
[PubMed PMID: 27247365]
[13]
Lee SJ,Vogelsang G,Flowers ME, Chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2003 Apr
[PubMed PMID: 12720215]
[14]
Elad S,Zadik Y,Zeevi I,Miyazaki A,de Figueiredo MA,Or R, Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation. 2010 Dec 15;
[PubMed PMID: 21119507]
[15]
Gálvez K,Muñoz P,Vera V,Arce C, Vitiligo type cutaneous manifestation of chronic graft-versus-host disease. Case report. Revista chilena de pediatria. 2018 Feb;
[PubMed PMID: 29664513]
Level 3 (low-level) evidence
[16]
Gandelman JS,Zic J,Dewan AK,Lee SJ,Flowers M,Cutler C,Pidala J,Chen H,Jagasia MH,Tkaczyk ER, The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Feb;
[PubMed PMID: 30219700]
[17]
Munir SZ,Aylward J, A Review of Ocular Graft-Versus-Host Disease. Optometry and vision science : official publication of the American Academy of Optometry. 2017 May
[PubMed PMID: 28422804]
[19]
Firoz BF,Lee SJ,Nghiem P,Qureshi AA, Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Archives of dermatology. 2006 Feb
[PubMed PMID: 16490845]
[20]
Vander Lugt MT,Braun TM,Hanash S,Ritz J,Ho VT,Antin JH,Zhang Q,Wong CH,Wang H,Chin A,Gomez A,Harris AC,Levine JE,Choi SW,Couriel D,Reddy P,Ferrara JL,Paczesny S, ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. The New England journal of medicine. 2013 Aug 8
[PubMed PMID: 23924003]
[21]
Ferrara JL,Harris AC,Greenson JK,Braun TM,Holler E,Teshima T,Levine JE,Choi SW,Huber E,Landfried K,Akashi K,Vander Lugt M,Reddy P,Chin A,Zhang Q,Hanash S,Paczesny S, Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood. 2011 Dec 15
[PubMed PMID: 21979939]
[22]
Korngold R,Marini JC,de Baca ME,Murphy GF,Giles-Komar J, Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2003 May
[PubMed PMID: 12766879]
[23]
Matsukuma KE,Wei D,Sun K,Ramsamooj R,Chen M, Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). Journal of gastrointestinal oncology. 2016 Apr
[PubMed PMID: 27034810]
[24]
Naymagon S,Naymagon L,Wong SY,Ko HM,Renteria A,Levine J,Colombel JF,Ferrara J, Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nature reviews. Gastroenterology & hepatology. 2017 Dec
[PubMed PMID: 28951581]
[25]
Glucksberg H,Storb R,Fefer A,Buckner CD,Neiman PE,Clift RA,Lerner KG,Thomas ED, Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974 Oct
[PubMed PMID: 4153799]
[26]
Rowlings PA,Przepiorka D,Klein JP,Gale RP,Passweg JR,Henslee-Downey PJ,Cahn JY,Calderwood S,Gratwohl A,Socié G,Abecasis MM,Sobocinski KA,Zhang MJ,Horowitz MM, IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. British journal of haematology. 1997 Jun
[PubMed PMID: 9217189]
Level 2 (mid-level) evidence
[27]
Cho C,Hsu M,Barba P,Maloy MA,Avecilla ST,Barker JN,Castro-Malaspina H,Giralt SA,Jakubowski AA,Koehne G,Meagher RC,O'Reilly RJ,Papadopoulos EB,Ponce DM,Tamari R,van den Brink MRM,Young JW,Devlin SM,Perales MA, Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis. Bone marrow transplantation. 2017 Dec
[PubMed PMID: 28991247]
[28]
Cahn JY,Klein JP,Lee SJ,Milpied N,Blaise D,Antin JH,Leblond V,Ifrah N,Jouet JP,Loberiza F,Ringden O,Barrett AJ,Horowitz MM,Socié G, Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood. 2005 Aug 15
[PubMed PMID: 15878974]
[29]
Müller JA,Zirafi O,Roan NR,Lee SJ,Münch J, Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD. Bone marrow transplantation. 2016 Aug
[PubMed PMID: 27042833]
[30]
Bergeron A,Cheng GS, Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation. Clinics in chest medicine. 2017 Dec;
[PubMed PMID: 29128013]
[31]
van der Meij BS,de Graaf P,Wierdsma NJ,Langius JA,Janssen JJ,van Leeuwen PA,Visser OJ, Nutritional support in patients with GVHD of the digestive tract: state of the art. Bone marrow transplantation. 2013 Apr
[PubMed PMID: 22773121]
[32]
Mays JW,Fassil H,Edwards DA,Pavletic SZ,Bassim CW, Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral diseases. 2013 May
[PubMed PMID: 23107104]